House
File
2141
-
Introduced
HOUSE
FILE
2141
BY
SHIPLEY
A
BILL
FOR
An
Act
relating
to
information
to
be
provided
by
the
department
1
of
public
health
regarding
vaccines
and
information
2
distributed
through
the
Iowa
immunization
program.
3
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4
TLSB
5774YH
(3)
88
pf/rh
H.F.
2141
Section
1.
IOWA
IMMUNIZATION
PROGRAM
——
INFORMATION
1
REQUIRED.
The
department
of
public
health
shall
require
2
that
vaccines
and
information
distributed
through
the
Iowa
3
immunization
program
include
a
copy
of
42
U.S.C.
§300aa-22,
4
and
a
statement
explaining
the
law
in
plain
language,
5
regarding
the
limitation
of
liability
of
a
manufacturer
of
a
6
vaccine,
including
the
excipients
added
to
the
vaccine,
for
7
a
vaccine-related
injury
or
death
resulting
from
unavoidable
8
adverse
side
effects
or
failure
to
provide
direct
warning
of
9
potential
dangers.
The
vaccines
and
information
distributed
10
shall
also
include
the
centers
for
disease
control
and
11
prevention
of
the
United
States
department
of
health
and
human
12
services
vaccine
excipient
summary
for
the
specific
vaccine
13
type
and,
unless
information
is
available
to
the
contrary,
a
14
statement
that
the
adjuvants
in
the
vaccine
have
inherent,
15
unavoidable
risks
and
have
not
been
scientifically
evaluated
16
for
long-term
adverse
events
or
against
the
adjuvants
of
any
17
other
vaccine.
18
EXPLANATION
19
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
20
the
explanation’s
substance
by
the
members
of
the
general
assembly.
21
This
bill
relates
to
the
Iowa
immunization
program
under
the
22
purview
of
the
department
of
public
health
(DPH)
that
includes
23
the
activities
funded
by
the
federal
vaccines
for
children
24
program.
25
The
bill
requires
DPH
to
require
that
vaccines
and
26
information
distributed
through
the
Iowa
immunization
27
program
include
certain
information.
The
information
28
required
includes:
a
copy
of
the
federal
law,
42
U.S.C.
29
§300aa-22,
relating
to
the
standards
of
responsibility
for
30
manufacturers
of
vaccines
that
provide
that
a
manufacturer
31
is
immune
from
liability
in
a
civil
action
for
damages
32
arising
from
a
vaccine-related
injury
or
death
associated
33
with
the
administration
of
a
vaccine
after
October
1,
1988,
34
if
the
injury
or
death
resulted
from
side
effects
that
were
35
-1-
LSB
5774YH
(3)
88
pf/rh
1/
2
H.F.
2141
unavoidable
even
though
the
vaccine
was
properly
prepared
1
and
was
accompanied
by
proper
directions
and
warnings,
or
2
solely
due
to
the
manufacturer’s
failure
to
provide
direct
3
warnings
to
the
injured
party
(or
the
injured
party’s
legal
4
representative)
of
the
potential
dangers
resulting
from
the
5
administration
of
the
vaccine
manufactured
by
the
manufacturer;
6
a
statement
explaining
the
law
in
plain
language
regarding
7
the
limitation
of
liability
of
a
manufacturer
of
a
vaccine,
8
including
the
excipients
added
to
the
vaccine;
the
centers
9
for
disease
control
and
prevention
of
the
United
States
10
department
of
health
and
human
services
vaccine
excipient
11
summary
for
the
specific
vaccine
type
and,
unless
information
12
is
available
to
the
contrary,
a
statement
that
the
adjuvants
13
in
the
vaccine
have
inherent,
unavoidable
risks
and
have
not
14
been
scientifically
evaluated
for
long-term
adverse
events
or
15
against
the
adjuvants
of
any
other
vaccine.
16
An
excipient
is
an
ingredient
contained
in
a
vaccine
in
17
addition
to
weakened
or
killed
disease
antigens.
An
adjuvant
18
is
an
excipient
that
is
added
to
the
vaccine
to
help
stimulate
19
a
stronger
immune
response
and
includes
aluminum
salts.
20
-2-
LSB
5774YH
(3)
88
pf/rh
2/
2